Abstract
Bone tissue engineering using polymer based scaffolds have been studied a lot in last decades. Considering the qualities of all the polymers desired to be used as scaffolds, Polycaprolactone (PCL) polyester apart from being biocompatible and biodegradable qualifies to an appreciable level due its easy availability, cost efficacy and suitability for modification. Its adjustable physio-chemical state, biological properties and mechanical strength renders it to withstand physical, chemical and mechanical, insults without significant loss of its properties. This review aims to critically analyse the efficacy of PCL as a biomaterial for bone scaffolds.
Keywords: Bone tissue engineering, Polycaprolactone, Scaffolds
1. Introduction
Bone, the mineralized connective tissue of the body consists of macrostructures (such as cancellous and cortical bone), microstructures (like osteons, and single trabeculae), sub-microstructures (lamellae), nano-structures (fibrillar collagen), and sub-nanostructures (minerals, and collagen molecules).1 The organic component of the bone comprises of collagen proteins predominantly type I collagen (90%) and non-collagenous proteins like, osteocalcin, osteopontin, bone sialoproteins and growth factors. The inorganic component consists mainly of calcium and phosphate ions which nucleate to form small crystals of hydroxyapatite.2,3 The interactions between collagen, hydroxyapatite, and various organic and inorganic components of bone lead to its structural organisation and typical mechanical properties (compressive strength, fracture toughness and tensile strength).4 Cortical porosity (average 10–30%) is due to its intracortical canals and spaces, while trabecular porosity (30–90%) is due to the intertrabecular marrow spaces. Porosity is reciprocally proportional to bone strength and stiffness. Cortical porosity of mandibular condyle is 3.53–3.98%, while trabecular porosity is 79.3%.5
Bone is a highly dynamic tissue wherein the old bone is replaced with the new bone continuously by bone remodeling. In the past few decades, bone tissue engineering has emerged as a promising strategy to overcome the shortcomings associated with the traditional techniques. It employs three components: cells, scaffolds and growth factors either alone or in combination with the aim to form neo-tissue at the site of bone loss. A bone scaffold is the 3D matrix framework that stimulates the attachment and proliferation of osteo-inductive cells on its surfaces.
The bone scaffold material can be divided into 3 generations, depending on the degree of integration by the recipient's bone.6 The first generation includes pure metals (stainless steel, titanium), metal alloys (aluminium, zirconium) and polymers (silicone, polypropylene, polymethyl methacrylate). This group of grafts often develop a fibrous layer on the bone contact surface, leading to a lack of osteointegration and loosening of the graft. The second generation of substitutes is coated with an additional supporting layer to prevent the formation and deposition of connective tissue on the graft and thereby facilitating complete osteointegration. This group includes hydroxyapatite, calcium metaphosphate and bioactive glass. The third generation uses a material closely related to bone and is characterized by high osteo-conductivity, osteo-inductivity and biodegradable.
The aim of this study is to provide a comprehensive review on the efforts made to fabricate PCL or its composite scaffolds and methods employed to improve its mechanical properties as well as cellular activity in bone tissue engineering.
1.1. Polymers as biomaterial for scaffolds
The characteristics of a biomaterial that must be scrutinized thoroughly before considering it for bone tissue engineering applications includes chemical composition, biological and structural characteristics, degradation behavior and fabrication process. Polymeric scaffolds are of considerable interest due to their distinctive features, such as ability to harbour multiple spatio-temporal cues, provide osteo-inductive niche to the resident or transplanted cells at the injury site, degradation rate similar to the rate of osteogenesis and integrate with the host tissue through extensive chemical modifications. Polymers used as biomaterial for bone tissue engineering can be natural or synthetic, biodegradable or nonbiodegradable.
Natural polymers: These polymers are biocompatible and bioactive, thus, aid in enhancement of the cell performance (adhesion and proliferation). However, they are difficult to engineer due to their limited processing abilities, possess high risk of contamination and exhibit batch-to-batch variability. Eg. bioactive proteins (silk, collagen, gelatin, fibrinogen, elastin, keratin, actin, and myosin), polysaccharides (cellulose, amylose, dextran, chitin, and glycosaminoglycans), or polynucleotides (DNA, RNA).7
Synthetic polymers: These polymers are highly popular as scaffold material, as have defined chemistry, easy processing and tailoring ability, and can be modified to achieve desired properties for specific applications. Other merits include cost efficacy, ability to be produced in large quantity uniformly and a longer shelf time. Also the physicochemical and mechanical properties such as tensile strength, elastic modulus, and degradation rate are comparable to bone. However, these polymers are not bioactive, hence, can elicit inflammatory responses inside the host. Polymers like, poly lactic acid (PLA), polyglycolic acid (PGA), poly-L-lactide (PLLA), poly ε-caprolactone (PCL), poly lactic-glycolic acid (PLGA) copolymers and poly hydroxy-alkanoates (PHA) are classified as synthetic polymers.15,16 Within the class of synthetic materials, PCL has recently drawn much attention for biomedical applications including bone tissue engineering.8, 9, 10
1.2. Poly ε-caprolactone (PCL)
PCL is a member of the biodegradable polyesters (others being PGA, PLLA). It is an aliphatic semi-crystalline polymer, with melting temperature ranging between 59 and 64 °C (i.e. above body temperature), glass transition temperature of −60 °C. Hence, at physiological temperature, the semi crystalline PCL attains a rubbery state resulting in its high toughness11 and superior mechanical properties (high strength, elasticity depending on its molecular weight). It is non-toxic and tissue compatible, hence widely used as resorbable sutures, as scaffolds in regenerative therapy and in drug delivery applications. PCL exhibits a longer degradation time (2–3 years) and is degraded by microorganisms or by hydrolysis of its aliphatic ester linkage under physiological conditions.12 Due to the presence of five hydrophobic –CH2 moieties in its repeating units, PCL degrades slowest among all the polyesters. The nano-fiber matrices made from polyesters follow an erosion rate of PGA > PLGA > PLLA > PCL.13
1.3. Fabrication of PCL scaffolds
The technique employed for fabricating PCL scaffolds depends upon the type of scaffold needed. For porous scaffolds, methods like: porogen leaching, saturation and release of CO2, 3D printing, phase separation technique and freeze-drying have been employed. However, for fabrication of fibrous scaffolds techniques like electrospinning and melt electrospinning have been used.14, 15, 16, 17, 18
1.3.1. A. Solvent casting and porogen leaching
Porosity is the key factor in designing of scaffolds for bone tissue engineering since proper pores are needed to permit tissue growth and nutrient diffusion. The technique utilizes soluble porogen particles (water soluble salts such as sodium chloride and sodium bicarbonate) embedded in polymer that forms pores in the polymer matrix upon removal. The pore size can be tailored by using different sizes and concentration of porogens. For instance, 1:1 wt/wt NaCl and NaHCO3 was used as a porogen in PCL solution to fabricate an interconnected scaffold having 70–80% porosities.19 Recently, solvent casting has been used in combination with particulate leaching method to generate 3D scaffolds. Others fabricated PCL 3D scaffolds after casting the PCL solution containing salt and polyethylene glycol as porogens onto a Teflon mold. These porogens were then removed to generate scaffolds of varying pore sizes.20,21
1.3.2. b. Electrospinning (ES)
ES until now is the most favorable technique to fabricate highly controllable and ultra-fine polymer fibers and 3D scaffolds. The technique is versatile and has the ability to process various polymer solutions and their blends such as PCL and Aluminum Oxide, recombinant spider silk protein and gelatin, PLA, PLGA, silk fibroin and polyurethane etc. Ke et al. fabricated PCL/Gelatin nanofibrous membranes using electrospinning and demonstrated their significant potential for bone regeneration.22 In another study, fibers using PCL/PLA blends were fabricated to prepare scaffolds from the nanofibrous structures. These scaffolds showed improved osteogenic differentiation of stem cells for cranial regeneration. The activation of BMP 2 signalling in these scaffolds further improved the osteogenic differentiation.23,24
1.3.3. c. Phase Separation technique
This includes either liquid or solid-liquid mixing generating polymer-poor and polymer-rich phases. On lowering the temperature freezing of solution occurs and removal of frozen solvent leads to pore formation. Phase separation results via varying the polymer concentration, using different solvents, or varying the cooling rate resulting in scaffolds with different morphology.25 Grandi et al. demonstrated the separation phase technique using calcium alginate to process PCL into required dimensions, which resembled the porosity and the homogeneous pore size distribution of the bone.26
1.3.4. d. 3D printing
Three-dimensional printing has evolved as a promising technology to fabricate scaffolds and complex structures with micron size precision and accuracy with homogenous distribution of cells within it.27 Recently, Cho et al. 3D printed a composite scaffold of PCL/hydroxyapatite (HA) melt with HA exposed onto the surface of scaffold for enhanced cellular response and bone regeneration.28 Similarly, in another study, PCL/HA with varying content of mineralization was fabricated using multi-material extrusion 3D printing system for osteochondral tissue engineering. Such scaffolds have ability to address the structural and compositional gradients found in osteo-chondral region. Thus, 3D printing can be utilized to make versatile scaffolds imitating extracellular matrix of the tissue using both natural and synthetic polymers.29
1.3.5. e. Melt electrospinning
The melt electrospinning utilizes polymer melts when compared to the polymer solution used in electrospinning. The principle remains same, the only difference is in the physical states of the polymer used, polymer melts are more viscous than the polymer solution. In a recent study, PCL fibers were developed for an application in oral and maxillofacial surgery. The fibers of 20 μm diameter were fabricated by spinning the PCL melt (melted at 73 °C) at a pressure of 1.2 bars and an acceleration voltage of 6 KV.30 Zaiss et al. employed melt electrospinning technique to fabricate 3D scaffolds on structured and curved metallic collectors. The scaffolds made had an average fiber diameter of 15 μm and pore size of 250 μm–300 μm. Melt electrospinning, unlike solution electrospinning can be used to fabricate fibers of diameter greater than sub microns.31
1.4. Surface modification of PCL
PCL is relatively hydrophobic in nature. For it to be used as scaffold, hydrophilicity is needed, and cellular compatibility needs to be enhanced. For maximum cell adhesion, optimal water contact angle values have been reported to be in the range of 45–70 °C or in the region of 30–60 °C. At very low contact angles water uptake increases leading to decreased protein adsorption needed for cell recognition and attachment. However very high contact angles and low surface energy causes low cell-conductive behavior and protein denaturation.32 Several attempts have been made to modify the surface of PCL, by coating the scaffold with composites of fibrin, fibronectin, gelatin, growth factors, and proteoglycans. Double protein-coated PCL scaffolds have demonstrated superior initial cell adhesion, proliferation, and colonization. While Arginine-glycine-aspartic acid (RGD) coating showed smoother surfaces, and early bone deposition onto scaffold surfaces, due to reorganization of the ECM matrix on the surface.33 Hydrophilicity of PCL surface can be enhanced by Plasma treatment (active screen plasma nitriding) and has shown improved cell attachment. However, this treatment leads to slower enzymatic degradation rate.34 Zander et al. (2012) modified PCL electrospun fibers by air plasma followed by covalent attachment of laminin.35 Gupta (2019) demonstrated that alkaline surface treatment (with controlled NaOH-concentration, reaction temperature, and treatment time) improves the surface morphology and cellular response of PCL. Increase intensity of treatment resulted in enhanced surface porosity (~60%), increased surface roughness (~700 nm), and improved cellular response till surface porosity reached ~35%.36
Rotbaum et al. (2019) studied the effect of pore geometry and size in 3D printed PCL scaffolds on their mechanical properties. Square pores (with dimensions 150–650 μm) had 59–79% porosity while quadrangular, hexagonal, triangular and complex pores had a constant porosity of approx. 70%. The mechanical properties were reported to be insensitive to strain rate and were strongly dependant on the pore size (porosity) rather than pore geometry.37
1.5. Blends of PCL
PCL scaffolds used earlier were unable to provide optimal mechanical strength and biocompatibility. Hence PCL blending with natural or synthetic polymer or ceramic was attempted. Incorporation of calcium phosphate-based ceramics, bioactive glasses and polymers into PCL led to improved biomaterials with better mechanical properties, controllable degradation rates, and enhanced bioactivity (Table 1). Lino (2019), blend PCL and poly-di-isopropyl fumarate enriched with Sr2+. In vitro, Blend +5% Sr2+ was pro-inflammatory and anti-osteogenic, Blend +1% Sr2+ released low quantities of cation; but was not cytotoxic for cultured macrophages; and demonstrated better osteo-compatibility. In vivo, Blend +1% Sr2+ significantly increased bone tissue regeneration without inducing any local inflammation.38 Hwang (2019) blend Cellulose acetate solutions and calcium lactate with PCL nanofibrous scaffold by electrospinning to enhance the bio-physio-chemical properties of the composite fiber.39
Table 1.
PCL Blend- Comparison of different materials used to blend with PCL along with technique employed and advantages/disadvantages.
| S No. | Types of polymers | Blending with | Fabrication Technique | References | Advantages/Disadvantages |
|---|---|---|---|---|---|
| 1 | Natural | PCL- Chitosan (CS) composite structure as 3D hydrogel | Lyophilization | Zhong 2011, Thuaksuban 2011 | Ratio is crucial. PCL/20%CS scaffolds showed good physical properties and cellular response. Increasing CS reduced the micro-groove pattern, surface roughness, tensile strength and elasticity of filaments, whilst compressive strength was not affected |
| Adding 5–10% Nanofibrillated CS made PCL solution electrospinnable. | Electrospinning | Fadaiea 2018 | Mechanical properties, wettability improved with enhanced tensile strength, Young's modulus, cell proliferation and adhesion. | ||
| Silk | Lyophilization | Serrano 2009, Lim 2012, Hu 2012, Chen 2004. |
Good cell adhesion, growth and proliferation, excellent biodegradability, biocompatibility but changes in silk content vary the results. | ||
| Spider silk and Gelatin | Electrospinning | Xiang 2011 | High porosity and good cytocompatibility. | ||
| Alginate | Electrospinning | Hu 2019 | Enriched cell adhesion, ECM interaction and angiogenesis | ||
| Collagen | Electrospinning | Zhang YZ 2005 | Linear increase in Human Dermal fibroblast density by 19.5% (2 days), 22.9% (4 days), and 31.8% (6 days). | ||
| 2 | Synthetic | PLLA and MWCNTs | Separation Phase | Amirian 2012 | Degradation kinetics can be controlled by varying MWCNTs content |
| PLA/HA | Electrospinning | Kareem 2019 | Higher bioactivity with gradual reduction in mechanical properties | ||
| Gravity spun PCL fibers with elastic electrospun Polyurethane (PU) fibers fabricated to PCL/PU | Solvent-Casting | Williamson 2006 | For vascular tissue. Lumen of PCL scaffold supports formation of stable functional endothelial cells monolayer and controls release of bioactive molecules. | ||
| PLGA | Electrospinning | Hiep 2010 | Increased biocompatibility at increasing % of PLGA, good cell adhesion and proliferation of fibroblast cells on electro-spun mats | ||
| PLLA-PCL in porous membranes | Freeze Extraction | . Haroosh 2012, Williamson 2006 | Increased degradation time of PLLA, but with a loss in mechanical properties | ||
| Polystyrene (PS) | Spin-coating | Ma 2012 | PCL-Polystyrene thin films. | ||
| PGA | Separation Phase | Grandi 2011 | Comparable porosity and pore size with bone. | ||
| PLA | Thermally induced nanofiber self-agglomeration (TISA), Electrospinning | Yao 2017 | Higher mechanical properties in vitro bioactivity; enhanced cell viability of hMSCs and osteogenic differentiation. | ||
| 3 | Ceramic | Forsterite (Mg2SiO4) | Solvent-Casting and Particle Leaching | Diba 2012 | Improves mechanical properties, bioactivity, biodegradability, non-cytotoxicity |
| Calcium Alginate | Separation Phase | Grandi 2011 | Resembled native bone porosity and homogeneous pore size | ||
| Aluminum oxide PCL(AL2O3) | Electrospinning | Dong 2012 | Mechanical properties improved | ||
| Magnesium Phosphate (MP-PCL | Particulate Leaching | Wu 2012 | Increased degradation time | ||
| Calcium Phosphate | GF-SEDA (Gas Foaming and Spontaneous Emulsion Droplets Adherence) | Bao TQ, Franco RA, Byong T (2012) | In vitro scaffold demonstrated significant and better cell adhesion, growth, and proliferation over the course of 5 days in culture. | ||
| Nanohydroxyapatite to form PCL/nHA | MM-M/LT (Modified Melt-Molding/Leaching) | Klein 1983, Freed 1994, Rezwan 2006, Liu 2012 |
Excellent biocompatibility in-vitro and in-vivo. Shown potential for cartilage tissue engineering |
||
| Bioactive glass microspheres and glass fibers from calcium phosphate (50P2O5 + 50CaO) glass | Solvent-Casting | Lei 2012, Ahmed 2008 | Improved performance | ||
| Polydiisopropyl fumarate (PDIPF) | Solvent –casting | Lino 2019, Fernandez JM et al., 2011 | Sr2+ replaces Ca2+ in Hydroxyapatite. The blend scaffold exhibited Improved physical, mechanical and osteoinductive properties. |
1.6. Effect of scaffold chemistry or surface modification of PCL scaffolds on bone regeneration
PCL due to its hydrophobic nature and absence of functional groups that enable cell growth and proliferation, restricts any cellular interactions. Therefore, there is a need to modify the surface of tissue engineered PCL scaffolds to enhance their cellular compatibility and bone regeneration ability.40 Several attempts have been made in this regard using techniques such as plasma deposition, starch-blending or attachment of mussel inspired material.41, 42, 43
The most commonly used technique to improve cellular interaction is to modify the substrate with the extracellular components or with mimicking synthetic peptides for example, arginine-glycine-aspartic acid (RGD), fibronectin, gelatin, fibrin. In a study, PCL scaffold modified with RGD peptide demonstrated improved BMSC attachment and cellular distribution, with increase in cell survival and growth.44 Attempts made to functionalize PCL fibers with RGD peptide showed improved cell attachment, proliferation and osteogenic activity of Saos-2 cells.45 When RGD was coated on PCL, the irradiated PCL surfaces were observed to be smoother, and promoted initial bone deposition onto scaffold surfaces, due to reorganization of the ECM matrix on the surface.46 Coating of PCL scaffold with composite of fibrin, fibronectin, gelatin, growth factors, and proteoglycans have also been reported. When PCL scaffolds were first coated with gelatin type B and then with fibronectin, it was observed that the double protein coating showed higher colonization of pre-osteoblast cells and influenced both the seeding density and subsequent differentiation into osteoblasts.47
Plasma treatment and plasma polymer deposition technique produces the surface of amine, carboxy, hydroxy and aldehyde groups on materials depending upon the gas that is fed. Amine surfaces have been coated mainly by using NH3, N2 or N2/H2 plasma treatments or alkyl amine plasma depositions.48, 49, 50 These groups increase the hydrophilicity of PCL surface and allow better cell adhesion. However, after the treatment the enzymatic degradation rate becomes slower.40
When PCL 3D scaffolds fabricated by additive manufacturing were coated with ethylene/nitrogen and hydrogen plasma treatment, it led to uniform distribution and penetration of plasma particles on it. This coating imparted uniform attachment and proliferation of Saos-2 cells.41 Zander et al. modified PCL Electrospun fibers by air plasma treatment, followed by the covalent attachment of laminin.35 Mussel inspired materials such as dopamine can be coated on the surface of a material by raising the pH without using solvents. Dopamine has abundant catechol and amine groups that can enhance cellular bioactivity of the synthetic polymers. PCL scaffolds when coated with polydopamine and functionalized with rhBMP2, showed improved surface wettability, cell proliferation and osteogenic ability.51 Polydopamine coating on electrospun PCL fibers can tune the loading and release rate from these fibers, and hence can be used to improve the delivery of growth factors required for bone tissue formation in scaffolds.43 As described earlier alkaline surface treatment improves the surface morphology and cellular response of PCL. Also, increased treatment intensity, leads to increased surface porosity, surface roughness and cellular response till surface porosity is ~35%.35 Hydroxyl functionalized PCL had 70% porosity and compressive modulus comparable to bone, and demonstrated enhanced cell adherence, better metabolic activity and osteogenic potential than PCL scaffolds.52
Altogether, these studies suggest that surface modification of PCL scaffolds enhances the cellular activity and their osteogenic potential, thus, overcoming the drawbacks of the synthetic polymer.
1.7. Effect of surface topology of PCL scaffolds on bone regeneration
Surface roughness is an easily tailorable and cost-effective factor that can influence cell behavior. The osteogenic ability of the hMSCs seeded on PCL scaffolds with surface roughness of Ra ~ 0.9–2.1 μm cultured in dexamethasone-deprived osteogenic induction medium and in basal growth medium was significantly superior to the cells cultured on tissue culture plate control in complete osteogenic induction medium with dexamethasone.53 The surface having the highest roughness (Ra = 293–445 nm) achieved by homogenous distribution of apatite layer led to improved cell viability and osteogenic ability of pre-osteoblast cells when soaked in simulated body fluid for 7 days.54
Pore size is another important scaffold characteristic that regulates cell binding, migration, tissue regeneration and deposition. The larger pore size allows efficient nutrient diffusion, waste removal and minimal cell-cell contact.55,56 Also, different pore sizes allow binding of different cell types on PCL scaffolds. Chondrocytes and osteoblasts showed higher cell proliferation in the PCL scaffold with the pore size of 380–405 μm and fibroblast proliferation was seen on scaffolds having pore size of 186–200 μm. Pore size of 290–310 μm demonstrated increased bone regeneration after implantation in rabbit cranial defect.57 While, a pore size larger than 400 μm favors angiogenesis and enhances bone forming ability of the scaffolds.58 The pore size of the PCL scaffold differentially regulates cell behavior in vitro, however, the scenario is different in vivo. A pore size of PCL scaffolds (350, 550, 800 μm) had limited influence on bone regeneration in immunocompromised mice model.59
1.8. Mechanical properties of PCL
The mechanical strength viz. compressive strength, elastic and tensile strength, fatigue of the scaffold should be sufficient to sustain and retain its properties even after implantation at high load bearing sites and perform appropriately until new tissue is able to restore the function. This would provide stable scaffold integration at the host site and subsequent reconstruction of the injured site while mechanically supporting it.60 Calcium phosphate materials, although approved by FDA as bone fillers and explored as bone scaffolds for regeneration, their mechanical properties still fall short of the functional tissues. Two approaches are being used to increase their strength. PCL was either printed along with CaP (co-deposited) followed by sintering to form a scaffold or was coated on the surface of printed and sintered CaP scaffolds. Both approaches showed increased strength and modulus when compared to only CaP scaffolds.61
Interestingly, interpenetrating hydrogels of different concentrations of gelatin methacrylate and pectin-g-PCL led to formation of robust hydrogel with increased compressive and tensile moduli after double crosslinking by UV light and Ca 2+ ions whereas crosslinking by UV light only led to reduction in mechanical properties. Further, these hydrogels showed increased growth of pre-osteoblasts cells in vitro, therefore, have great potential for bone regeneration.62
When Young's moduli of electrospun PCL fiber and PCL fiber scaffolds was measured using macro-tensile testing instrument, and atomic force microscopy, Young's modulus for fiber scaffold was 3.8 ± 0.8 MPa while for single fiber was 3.7 ± 0.7 GPa. The difference was due to the random structure of fiber scaffold.63 Bulk PCL has tensile strength of about 25–43 MPa and elastic modulus of about 330–360 MPa. In comparison porous and fibrous PCL scaffolds have low tensile strength and elastic modulus, due to their pore structure.64 Blending PCL with different type of ceramic materials improves the mechanical properties of PCL scaffold for bone tissue engineering (Table 2).
Table 2.
Changes in mechanical properties of PCL and blend PCL.
| S N | Mechanical properties | Blending material | Mechanical properties (MPa) |
References | |
|---|---|---|---|---|---|
| Pure PCL | Blend PCL | ||||
| 1 | . Compressive modulus | Magnesium Phosphate | 4.32 ± 0.13 | 2.37 ± 0.15 | WU 2012 |
| 2 | Elastic modulus Compressive stress | Mg 2SiO4 | 3.1(salt leaching) 0.0024 (solvent casting) |
6.9 0.3 |
Diba 2011 |
| 3 | Tensile Stress | Al2 O3 | 3.4 | 7.3 | Dong 2012 |
| 4 | Tensile Stress | BGMs | 14 | 17.5 | McClure 2012 |
| 5 | Young's Modulus Max Tensile strength |
Fish Bone Extract (FBE) | 9.18–9.42 82.3–97.4 |
Heo 2018 | |
1.9. Degradation behavior of PCL
PCL exhibits slow degradation rate (3–4 years). It degrades through hydrolytic cleavage of ester groups.65 Kulkarni (2008) studied the degradation of PCL and its copolymers and demonstrated enzymatic and hydrolytic degradation of PCL homopolymer.66 Among the polyesters, PCL degradation is the slowest due to presence of 5-CH2 moieties in its repeating units. In an attempt to accelerate the degradation time of PCL, Wu (2012) used magnesium phosphate and demonstrated a faster degradation rate.67
Bioactive Glass Microspheres reinforced PCL exhibited excellent mechanical properties, biocompatibility, bioactivity and faster degradation rate, but with increased weight loss and water absorption.68 Diba (2011) accelerated the degradation time of PCL by fabricating PCL-forsterite- nano-composites, however that too increased weight loss and water absorption.69 A blend with Chitosan has shown to cause an increase in water uptake, but decrease in the degradation rate.70 Arginine-glycine-aspartic acid (RGD) has also been used to modify PCL to decrease the time degradation.46 Spalthoff (2018) studied PCL-TCP scaffold pre-augmented scapula prior to a potential flap-raising procedure in a sheep and observed that a fair amount of the scaffold material was degraded and replaced by vital bone.71
1.10. Cellular bioactivity on PCL scaffolds
Scaffolds can elicit host immune response leading to failure of implants. The biocompatibility can be improved by adding Aluminum oxide (Al2O3) and Hydroxyapatite (HA) to PCL nano-composite scaffolds.72,73 Growth of cells has been reported to be significantly higher in blend scaffolds like recombinant spider silk protein/PCL/Gt, PCL/silk fibroin composite scaffolds, PCL/biphasic calcium phosphate hybrid composite scaffolds, and PCL/chitosan composite scaffold than pure PCL.74, 75, 76 Addition of HA to PCL/SF composite scaffold allows increased cell proliferation, but decreased collagen- I production. Addition of bone morphogenetic protein 4-expressing bone marrow stromal cells strongly favours osteo-inductivity.77,78 Lee et al. (2019) designed a- 3D PCL scaffold, which exhibited osteo-induction both in-vitro and in-vivo when isolated human tonsil-derived mesenchymal stem cells were cultured on the scaffolds. The cells rapidly differentiated into osteoblast-like cells with osteo-promoting capabilities. The scaffolds were then implanted in rabbit calvarial defect for enhanced vessel and bone regeneration.79 Lin 2019 prepared PCL composite membrane containing 20 wt% cobalt-substituted hydroxyapatite (CoHA) powders by solvent casting for local release of cobalt ion to reduce infection and inflammation. Significantly increased cell proliferation (over 90% after 7 days of culture), calcium deposition, and good antibacterial effect was observed.80 Park (2019) assessed the effectiveness of a tonsil-derived mesenchymal stem cell on a transplanted PCL/beta-tricalcium phosphate scaffold on rabbit mandible in a 10 × 8-mm bone defect at 12 weeks and observed extended dense new bone masses.81 Ho (2018) studied the effects of Biodentine/PCL scaffold with odontogenesis properties on human dental pulp cells. The Biodentine/PCL scaffolds were fabricated with uniform macropores 550 μm and interconnections using an extrusion printer. The mechanical properties showed their compressive strength of 6.5 MPa, bioactivity, and proliferation and odontogenic differentiation of human dental pulp cells cultured on the scaffolds exhibited a good apatite-forming ability and capability to support proliferation and differentiation.82
Fedore (2017) fabricated PCL scaffolds using extrusion deposition and coated some with Polyethylene glycol (PEG) hydrogel that inhibits mineralization and cultured calvarial cells for osteoblastic differentiation and mineralization. Uncoated PCL scaffolds showed better differentiation of osteoblasts.83 Wu (2019) fabricated 3D-printed calcium silicate, PCL, and decellularized extracellular matrix scaffolds and observed them to exhibit excellent biocompatibility, cellular adhesion, proliferation, and differentiation by increasing the expression of osteogenic-related genes.84 da Cunha 2019 fabricated PCL-Biosilicate scaffold using extrusion printer, with 0°/90° pore sizes and pore interconnectivity, which led to 57% increase in the stiffness of scaffold, without increasing any toxicity.85 González-Gil (2019) used a bone non-union model in Sprague-Dawley rats in six groups: control, live bone allograft, rhBMP-2 in collagen; acellular PCL; PCL with periosteum-derived MSCs, and PCL containing bone marrow-derived MSCs. Significant new bone formation was seen in LBA, CSBMP2 and PCLPMSCs groups at 8 weeks. However, at 10 weeks, green fluorescent protein positive cells were detected only in LBA group in the outer cortical bone in close contact with the periosteum.86 Nguyen 2019 conjugated a ‘smart’ Poly N-isopropyl acrylamide to fabricate PCL bead surfaces to serve as a thermo-responsive macrocarrier for non-invasive detachment of cells, and allowed human dermal fibroblasts and mesenchymal stem cells to adhere, and proliferate.87
Fuchs (2019) developed PCL scaffolds via melt electrospinning writing (MEW), and core membrane via film casting. PCL scaffolds and core membranes demonstrated good cytocompatibility for all cell lines, which even enhanced by fusing both components together.88 Wei (2019) developed a gelatin collagen, PCL skin substitute using two different GC:PCL ratios (1:8 and 1:20). In vitro test results showed better cell proliferation in the scaffold with a lower collagen content. Hence a lower collagen and higher PCL scaffold was seeded with adipose-derived stem cells and studied for animal wound healing, which showed significant promotion in wound healing and skin regeneration.89
1.11. In vivo studies
Also several studies have been done and a few are summarized in Table 3.
Table 3.
In vivo studies using PCL based scaffolds.
| S No. | Scaffold used | Experimented on | Inference | Reference |
|---|---|---|---|---|
| 1 | 10% HA reinforced PCL manufactured by solvent casting and particulate leaching method | Rabbits with calvarial bone defect MG-63 pre-osteoblast-like cells were cultured |
Increased cell proliferation and cell adhesion | Kim 2013 |
| 2 | 13%, 20%, 26% (v/v) uHA (urchin-like) dHA (MG2+-doped) 10% chloride crystals reinforced PCL by Solvent casting and Particulate leaching method | Rabbits with distal femoral condyles defects MG-63 osteoblast-like cells were cultured |
Increased Mechanical response, Higher ALP activity Higher proliferation, No inflammation. Good regeneration |
Guarino 2016 |
| 3 | PCL/HA scaffolds (60/40 w/w), realized via FDM immersed in unprocessed bone marrow blood (UBMB) taken from rabbits to create a coating and the formation of marrow clots (MC). | Rabbits with condyle and distal femur fractures | Better adhesion and proliferation and Improved osteogenic differentiation was observed. | Zheng 2017 |
| 4 | PCL/PLGA/duck beak scaffold | New Zealand White rabbits with 5 mm critical defect in diaphysis of left radius | Scaffold promotes new bone formation | Lee 2016 |
| 5 | 3D electrospun PCL/PLA blend (mass ratio: 4/1) nanofibrous scaffolds | Critical-sized cranial bone defect in mouse | strongly favorable for hMSCs osteogenic differentiation and cranial bone formation. | Yao 2017 |
Although it is a challenge to achieve the desired level of cell density, vascularisation and faster tissue maturation, successful bone constructs have been demonstrated using polymers specially PCL, which exhibited the greatest success among other polymers. However, a closer replication of cell's natural environment and stimuli can maximize osteogenesis.
Scaffold-induced cell homing by controlled release of chemokines and various other methods is being investigated. Several key chemokine receptors (CCR1, CXCR4, CXCR5 and CXCR6) are important factors in attracting stem cells.90,91 Owing to the advancements in the 3D bioprinting technologies, a precise control over microarchitecture and spatial content of the construct is increasing credibly. The scope for creating complex PCL scaffolds tailored to patient-specific cost effective applications in the future is vast.
2. Conclusion
PCL polyester has easy availability, is relatively inexpensive and can be modified to adjust its chemical and biological properties, physio-chemical state, degradability and mechanical strength and make it useable without significant loss of properties. Its longer degradation time makes it popular for use for replacement of hard tissues, load-bearing tissues by enhancing stiffness, and for soft tissues by decreasing its molecular weight and degradation time.
Declaration of competing interest
Authors have no conflict of interest to disclose.
Acknowledgements
Indian Council of Medical Research (Bioengineering) :Biomaterial for designing of mandibular bony scaffold: Evaluation of polymer-ceramic nano composite scaffold with BMP for critical size mandibular defect. (5/3/8/290/2015-ITR: 28,09,800)
References
- 1.Rho J.Y., Kuhn-Spearing L., Zioupos P. Mechanical properties and the hierarchical structure of bone. Med Eng Phys. 1998;20(2):92–102. doi: 10.1016/s1350-4533(98)00007-1. [DOI] [PubMed] [Google Scholar]
- 2.Florencio-Silva R., Sasso G.R., Sasso-Cerri E., Simões M.J., Cerri P.S. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Res Int. 2015;2015:421746. doi: 10.1155/2015/421746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Weiner S., Traub W. Bone structure: from angstroms to microns. FASEB J. 1992;6(3):879–885. [PubMed] [Google Scholar]
- 4.Weiner S., Traub W. Bone structure: from angstroms to microns. FASEB J. 1992;6(3):879–885. [PubMed] [Google Scholar]
- 5.Renders G.A.P., Mulder L., van Ruijven L.J., van Eijden T.M.G.J. Porosity of human mandibular condylar bone. J Anat. 2007 Mar;210(3):239–248. doi: 10.1111/j.1469-7580.2007.00693.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Amini A.R., Laurencin C.T., Nukavarapu S.P. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2012;40(5):363–408. doi: 10.1615/critrevbiomedeng.v40.i5.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Stevens B., Yang Y., Mohandas A., Stucker B., Nguyen K.T. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J Biomed Mater Res B Appl Biomater. 2008;85(2):573–582. doi: 10.1002/jbm.b.30962. [DOI] [PubMed] [Google Scholar]
- 8.Nair L.S., Laurencin C.T. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32(8-9):762–798. [Google Scholar]
- 9.Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cells Mater. 2003;20(5):1–16. doi: 10.22203/ecm.v005a01. [DOI] [PubMed] [Google Scholar]
- 10.Mondal D., Griffith M., Venkatraman S.S. Polycaprolactone-based biomaterials for tissue engineering and drug delivery: current scenario and challenges. Int J Polym Mater Polym Biomater. 2016;65(5):255–265. [Google Scholar]
- 11.Bezwada R.S., Jamiolkowski D.D., Lee I.Y. Monocryl® suture, a new ultra-pliable absorbable monofilament suture. Biomaterials. 1995;16:1141–1148. doi: 10.1016/0142-9612(95)93577-z. [DOI] [PubMed] [Google Scholar]
- 12.Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997 Oct 13;28(1):5–24. doi: 10.1016/s0169-409x(97)00048-3. [DOI] [PubMed] [Google Scholar]
- 13.Engelberg I., Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials. 1991 Apr;12(3):292–304. doi: 10.1016/0142-9612(91)90037-b. [DOI] [PubMed] [Google Scholar]
- 14.Pitt C.G., Chasalow F.I., Hibionada Y.M., Klimas D.M., Schindler A. Aliphatic polyesters. I. The degradation of poly(ε‐caprolactone) in vivo. J Appl Polym Sci. 1981;26:3779–3787. [Google Scholar]
- 15.You Y., Min B.M., Lee S.J., Lee T.S., Park W.H. In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly(lactide‐co‐glycolide) J Appl Polym Sci. 2005;95(2):193–200. [Google Scholar]
- 16.Chen G., Ushida T., Tateishi T. A biodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res. 2000;51(2):273–279. doi: 10.1002/(sici)1097-4636(200008)51:2<273::aid-jbm16>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- 17.Chen G., Ushida T., Tateishi T. Preparation of poly (L-Lactic acid) and poly (DL-lactic-co-glycolic acid) foams by use of ice microparticules. Biomaterials. 2001;22:2563–2567. doi: 10.1016/s0142-9612(00)00447-6. [DOI] [PubMed] [Google Scholar]
- 18.Ma J., Wang H., He B., Chen J. A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts. Biomaterials. 2001 Feb;22(4):331–336. doi: 10.1016/s0142-9612(00)00188-5. [DOI] [PubMed] [Google Scholar]
- 19.Fabbri P., Bondioli F., Messori M., Bartoli C., Dinucci D., Chiellini F. Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering. J Mater Sci Mater Med. 2010;21(1):343–351. doi: 10.1007/s10856-009-3839-5. [DOI] [PubMed] [Google Scholar]
- 20.Thadavirul N., Pavasant P., Supaphol P. Development of polycaprolactone porous scaffolds by combining solvent casting, particulate leaching, and polymer leaching techniques for bone tissue engineering. J Biomed Mater Res A. 2014;102(10):3379–3392. doi: 10.1002/jbma.35010. [DOI] [PubMed] [Google Scholar]
- 21.Cui Z., Lin L., Si J. Fabrication and characterization of chitosan/OGP coated porous poly(ε-caprolactone) scaffold for bone tissue engineering. J Biomater Sci Polym Ed. 2017;28(9):826–845. doi: 10.1080/09205063.2017.1303867. [DOI] [PubMed] [Google Scholar]
- 22.Ke R., Yi W., Tao S., Wen Y., Hongyu Z. Electro spun PCL/gelatin composite nanofiber structures for effective guided bone regeneration membranes. Mater Sci Eng C. 2017;78:327–332. doi: 10.1016/j.msec.2017.04.084. [DOI] [PubMed] [Google Scholar]
- 23.Miszuk J.M., Xu T., Yao Q. Functionalization of PCL-3D electrospun nanofibrous scaffolds for improved BMP2-induced bone formation. Appl Mater Today. 2018;10:194–202. doi: 10.1016/j.apmt.2017.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mooney D.J., Baldwin D.F., Suh N.P., Vacanti J.P., Langer R. Novel approach to fabricate porous sponges of poly (D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 1996 Jul;17(14):1417–1422. doi: 10.1016/0142-9612(96)87284-x. [DOI] [PubMed] [Google Scholar]
- 25.Harris L.D., Kim B.S., Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res. 1998 Dec 5;42(3):396–402. doi: 10.1002/(sici)1097-4636(19981205)42:3<396::aid-jbm7>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- 26.Grandi C., Di Liddo R., Paganin P. Porous alginate/poly(ε-caprolactone) scaffolds: preparation, characterization and in vitro biological activity. Int J Mol Med. 2011;27(3):455–467. doi: 10.3892/ijmm.2010.593. [DOI] [PubMed] [Google Scholar]
- 27.Do A.V., Khorsand B., Geary S.M., Salem A.K. 3D printing of scaffolds for tissue regeneration applications. Adv Healthc Mater. 2015;4(12):1742–1762. doi: 10.1002/adhm.201500168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cho Y.S., Choi S., Lee S.H., Kim K.K., Cho Y.S. Assessments of polycaprolactone/hydroxyapatite composite scaffold with Enhanced biomimetic mineralization by exposure to hydroxyapatite via a 3D-printing system and alkalin eerosion. Eur Polym J. 2019;113:340–348. [Google Scholar]
- 29.Bittner SM, Smith BT, Gomez LD. Fabrication and mechanical characterization of 3D printed vertical uniform and gradient scaffolds for bone and osteochondral tissue engineering. Acta Biomater. 2019;90:37–48. doi: 10.1016/j.actbio.2019.03.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fuschs A., Youssef A., Seher A. Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration – a pilot study in vitro. BMC Oral Health. 2019;19:28–38. doi: 10.1186/s12903-019-0717-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zaiss S., Brown T.D., Reichart J.C., Berner A. Poly(ε-caprolactone) scaffolds fabricated by melt electrospinning for bone tissue engineering. Materials (Basel) 2016;9(4):232–247. doi: 10.3390/ma9040232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Schugens C., Maquet V., Grandfils C., Jerome R., Teyssie P. Biodegradable and macroporous polylactide implants for cell transplantation: 1. Preparation of macroporous polylactide supports by solid-liquid phase separation. Polymer. 1996;37(6):1027–1038. doi: 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
- 33.Schugens C., Maquet V., Grandfils C., Jerome R., Teyssie P. Polylactide macroporous biodegradable implants for cell transplantation. II. Preparation of polylactide foams by liquid-liquid phase separation. J Biomed Mater Res. 1996 Apr;30(4):449–461. doi: 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
- 34.Gaona L.A., Ribelles J.L.G., Perilla J.E., Lebourg M. Hydrolytic degradation of PLLA/PCL microporous membranes prepared by freeze extraction. Polym Degrad Stab. 2012;97(9):1621–1632. [Google Scholar]
- 35.Zander N.E., Orlicki J.A., Rawlett A.M., Beebe T.P. Quantification of protein incorporated into electrospun Polycaprolactone Tissue Engineering scaffolds. ACS Appl Mater Interfaces. 2012;4:2074–2081. doi: 10.1021/am300045y. [DOI] [PubMed] [Google Scholar]
- 36.Gupta D., Singh A.K., Kar N., Dravid A. Bellare J Modelling and optimization of NaOH-etched 3-D printed PCL for enhanced cellular attachment and growth with minimal loss of mechanical strength. Mater Sci Eng C Mater Biol Appl. 2019;98:602–611. doi: 10.1016/j.msec.2018.12.084. [DOI] [PubMed] [Google Scholar]
- 37.Rotbauma Y., Puiub C., Rittela D., Domingos M. Quasi-static and dynamic in vitro mechanical response of 3D printed scaffolds with tailored pore size and architectures. Mater Sci Eng. 2019;C96:176–182. doi: 10.1016/j.msec.2018.11.019. [DOI] [PubMed] [Google Scholar]
- 38.Lino A.B., Berenice A., mcCarthy A., Desmond A., Fernandez J.M. Evaluation of strontium-containing PCL-PDIPF scaffolds for bone tissue engineering: in vitro and in vivo studies. Ann Biomed Eng. 2019;47(3):902–912. doi: 10.1007/s10439-018-02183-z. [DOI] [PubMed] [Google Scholar]
- 39.Hwang T.I., Kim J.I., Joshi M.K., Park C.H., Kim C.S. Simultaneous regeneration of calcium lactate and cellulose into PCL nanofiber for biomedical application. Carbohydr Polym. 2019 May 15;212:21–29. doi: 10.1016/j.carbpol.2019.01.085. [DOI] [PubMed] [Google Scholar]
- 40.Fu X., Sammons R.L., Bertoti I., Jenkins M.J., Dong H. Active screen plasma surface modification of polycaprolactone to improve cell attachment. J Biomed Mater Res Part B. 2012;100B:314–320. doi: 10.1002/jbm.b.31916. [DOI] [PubMed] [Google Scholar]
- 41.Domingos M., Intranuovo F., Gloria A. Improved osteoblast cell affinity on plasma-modified 3-D extruded PCL scaffolds. Acta Biomater. 2013;9(4):5997–6005. doi: 10.1016/j.actbio.2012.12.031. [DOI] [PubMed] [Google Scholar]
- 42.Sobral J.M., Caridade S.G., Sausa R.A., Mano J.F., Reis R.L. Three-dimensional plotted scaffolds with controlled pore size gradients: effect of scaffold geometry on mechanical performance and cell seeding efficiency. Acta Biomater. 2011;7(3):1009–1018. doi: 10.1016/j.actbio.2010.11.003. [DOI] [PubMed] [Google Scholar]
- 43.Jiang J., Xei J., Ma B., Bartlett D.E., Xu A., Wang C.H. Mussel-inspired protein-mediated surface functionalization of electrospun nanofibers for pH-responsive drug delivery. Acta Biomater. 2014;10(3):1324–1332. doi: 10.1016/j.actbio.2013.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang H., Lin C.Y., Hollister S.J. The interaction between bone marrow stromal cells and RGD-modified three-dimensional porous polycaprolactone scaffolds. Biomaterials. 2009;30(5):4063–4069. doi: 10.1016/j.biomaterials.2009.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Guler Z., Silva J.C., Sarac A.S. RGD functionalized poly(ε-caprolactone)/poly(m-anthranilic acid) electrospun nanofibers as high-performing scaffolds for bone tissue engineering RGD functionalized PCL/P3ANA nanofibers. Biomaterials. 2017;66(3):139–148. [Google Scholar]
- 46.Zheng W., Wang Z., Song L. Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials. 2012;33(10):2880–2891. doi: 10.1016/j.biomaterials.2011.12.047. [DOI] [PubMed] [Google Scholar]
- 47.Declercq H.A., Desmet T., Berneel E.E.M., Dubruel P., Cornelissen M.J. Synergistic effect of surface modification and scaffold design of bioplotted 3-D poly caprolactone scaffolds in osteogenic tissue engineering. Acta Biomater. 2013;9(8):7699–7708. doi: 10.1016/j.actbio.2013.05.003. [DOI] [PubMed] [Google Scholar]
- 48.Singh N.L., Qureshi A., Mukherjee S., Rakshit A.K., Tripathi A., Avasthi D.K. Surface modification of polymeric blends by nitrogen plasma implantation. Surf Coat Technol. 2007;201(19–20):8278–8281. [Google Scholar]
- 49.Salerno S., Piscioneri A., Laera S. Improved functions of human hepatocytes on NH3 plasma-grafted PEEK-WC-PU membranes. Biomaterials. 2009;30:4348–4356. doi: 10.1016/j.biomaterials.2009.04.052. [DOI] [PubMed] [Google Scholar]
- 50.Lopez L.C., Belviso M.R., Gristina R., Nardulli M., d'Agostino R., Favia P. Plasmatreated nitrogen-containing surfaces for cell adhesion: the role of the polymeric substrate. Plasma Process Polym. 2007;4(S1):S402–S405. [Google Scholar]
- 51.Lee S.J., Lee D., Yooh T.R. Surface modification of 3D-printed porous scaffolds via mussel-inspired polydopamine and effective immobilization of rhBMP-2 to promote osteogenic differentiation for bone tissue engineering. Acta Biomater. 2016;40:182–191. doi: 10.1016/j.actbio.2016.02.006. [DOI] [PubMed] [Google Scholar]
- 52.Seyednejad H., Gawlitta D., Dhert W.J.A., Nostrum C.F.V., Vermonden T., Hennink W.E. Preparation and characterization of a three-dimensional printed scaffold based on a functionalized polyester for bone tissue engineering applications. Acta Biomater. 2011;7(5):1999–2006. doi: 10.1016/j.actbio.2011.01.018. [DOI] [PubMed] [Google Scholar]
- 53.Fala Torres A.B., Chamley M., Goren T. Osteogenic differentiation of human mesenchymal stem cells in the absence of osteogenic supplements: a surface-roughness gradient study. Acta Biomater. 2015;28:64–75. doi: 10.1016/j.actbio.2015.09.028. [DOI] [PubMed] [Google Scholar]
- 54.Kim Y.B., Kim G.H. Highly roughened polycaprolactone surfaces using oxygen plasma-etching and invitro mineralization for bone tissue regeneration: fabrication, characterization, and cellular activities. Biointerfaces. 2015;125:181–189. doi: 10.1016/j.colsurfb.2014.11.033. [DOI] [PubMed] [Google Scholar]
- 55.Van Tienen T.G., Heijkants R.G.J.C., Buma P., De Groot J.H., Pennings A.J., Veth R.P.H. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials. 2002;23:1731–1738. doi: 10.1016/s0142-9612(01)00280-0. [DOI] [PubMed] [Google Scholar]
- 56.Zeltinger J., Sherwood J.K., Graham D.A., Mueller R., Griffith L.G. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7:557–572. doi: 10.1089/107632701753213183. [DOI] [PubMed] [Google Scholar]
- 57.Oh S.H., Park I.K., Kim J.M., Lee J.H. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials. 2007;28(9):1664–1671. doi: 10.1016/j.biomaterials.2006.11.024. [DOI] [PubMed] [Google Scholar]
- 58.Bobbert F.S.L., Zadpoor A.A. Effects of bone substitute architecture and surface properties on cell response, angiogenesis, and structure of new bone. J Mater Chem B. 2017;5:6175–6192. doi: 10.1039/c7tb00741h. [DOI] [PubMed] [Google Scholar]
- 59.Roosa S.M., Kempainnen J.M., Moffit E.N., Krebsbach P.H., Hollister S.J. The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A. 2010;92(1):359–368. doi: 10.1002/jbm.a.32381. [DOI] [PubMed] [Google Scholar]
- 60.Prasadh S., Wong R.C.W. Unravelling the mechanical strength of biomaterials used as a bone scaffold in oral and maxillofacial defects. Oral Sci Int. 2018;15(2):48–55. [Google Scholar]
- 61.Vella J.B., Trombetta R.P., Hoffman M.D., Inzana J., Awad H., Benoit D.S.W. Three-dimensional printed calcium phosphate and poly(caprolactone) composites with improved mechanical properties and preserved microstructure. J Biomed Mater Res A. 2018;106(3):663–672. doi: 10.1002/jbm.a.36270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Fares M.M., Shirzaei Sani E., Portillo Lara F., Oliviera R.B., Khademhosseini A., Annabi N. Interpenetrating network gelatin methacryloyl (GelMA) and pectin-g-PCL hydrogels with tunable properties for tissue engineering. Biomater Sci. 2018;26(11):2938–2950. doi: 10.1039/c8bm00474a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Croisier F., Duwez A.S., Jerome C. Mechanical testing of electrospun PCL fibers. Acta Biomater. 2012;8(1):218–224. doi: 10.1016/j.actbio.2011.08.015. [DOI] [PubMed] [Google Scholar]
- 64.Azevedo M.C., Reis R.L., Claase B.M., Grijpma D.W., Feijen J. Development and properties of polycaprolactone/hydroxyapatite composite biomaterials. J Mater Sci Mater Med. 2003 Feb;14(2):103–107. doi: 10.1023/a:1022051326282. [DOI] [PubMed] [Google Scholar]
- 65.Pena J., Corrales T., Izquierdo-Barba I., Doardrio A.L., Vallet Regi M. Long term degradation of poly(3-caprolactone) films in biologically related fluids. Polym Degrad Stab. 2006;91:1424–1432. [Google Scholar]
- 66.Kulkarni A., Reiche J., Hartman J., Kratz K., Lendlein A. Selective enzymatic degradation of poly (ε caprolactone) containing multiblock copolymers. Eur J Pharm Biopharm. 2008;68(1):46–56. doi: 10.1016/j.ejpb.2007.05.021. [DOI] [PubMed] [Google Scholar]
- 67.Wu F., Liu C.S., Neil D.O., Wei J., Ngothai Y. Fabrication and properties of porous scaffold of magnesium phosphate/polycaprolactone biocomposite for bone tissue engineering. Appl Surf Sci. 2012;258(19):7589–7595. [Google Scholar]
- 68.Lei B., Shin K.H., Noh D.Y., Koh Y.H., Choi W.Y., Kim H.E. Bioactive glass microspheres as reinforcement for improving the mechanical properties and biological performance of poly(e‐caprolactone) polymer for bone tissue regeneration. J Biomed Mater Res Part B. 2012;100B:967–975. doi: 10.1002/jbm.b.32659. [DOI] [PubMed] [Google Scholar]
- 69.Diba M., Fathi M.H., Kharaziha M. Novel fosterite/Polycaprolactone nanocomposite scaffold for tissue engineering applications. Mater Lett. 2011;65(12):1931–1934. [Google Scholar]
- 70.Zhong X., Ji C., Chan A., Kazarian S., Ruys A., Dehghani F. Fabrication of chitosan/poly(ε-caprolactone) composite hydrogels for tissue engineering applications. J Mater Sci Mater Med. 2011 Feb;22(2):279–288. doi: 10.1007/s10856-010-4194-2. [DOI] [PubMed] [Google Scholar]
- 71.Spalthoff S., Zimmerer R., Dittmann J., Korn P., Gellrich N.C., Jehn P. Scapula pre-augmentation in sheep with polycaprolactone tricalcium phosphate scaffolds. J Stomatol Oral Maxillofac Surg. 2018 Oct 25 doi: 10.1016/j.jormas.2018.10.001. pii: S2468-7855(18)30208-8. [DOI] [PubMed] [Google Scholar]
- 72.Dong Z., Wu Y., Wang Q., Xie C., Ren Y., Clark R.L. Reinforcement of electrospun membranes using nanoscale Al2O3 whiskers for improved tissue scaffolds. J Biomed Mater Res A. 2012;100A:903–910. doi: 10.1002/jbm.a.34027. [DOI] [PubMed] [Google Scholar]
- 73.Yu H., Wooley P.H., Yang S.Y. Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells. J Orthop Surg Res. 2009;4:5. doi: 10.1186/1749-799X-4-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Xiang P., Li M., Zhang C.Y., Chen D.L., Zhou Z.H. Cytocompatibility of electrospun nanofiber tubular scaffolds for small diameter tissue engineering blood vessels. Int J Biol Macromol. 2011;49(3):281–287. doi: 10.1016/j.ijbiomac.2011.05.004. [DOI] [PubMed] [Google Scholar]
- 75.Chen G., Zhou P., Mei N. Silk fibroin modified porous poly(ε-caprolactone) scaffold for human fibroblast culture in vitro. J Mater Sci Mater Med. 2004;15(6):671–677. doi: 10.1023/b:jmsm.0000030208.89523.2a. [DOI] [PubMed] [Google Scholar]
- 76.Bao T.Q., Franco R.A., Lee B.T. Preparation and characterization of a novel 3D scaffold from poly(ϵ-caprolactone)/biphasic calcium phosphate hybrid composite microspheres adhesion. Biochem Eng J. 2012;64:76–83. [Google Scholar]
- 77.Savarino L., Baldini N., Greco M. The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials. 2007;28(20):3101–3109. doi: 10.1016/j.biomaterials.2007.03.011. [DOI] [PubMed] [Google Scholar]
- 78.Li L.H., Qian Y.N., Jiang C. The use of hyaluronan to regulate protein adsorption and cell infiltration in nanofibrous scaffolds. Biomaterials. 2012;33(12):3428–3445. doi: 10.1016/j.biomaterials.2012.01.038. [DOI] [PubMed] [Google Scholar]
- 79.Lee S.J., Won J.E., Han C. A three-dimensionally printed scaffold grafted with bone forming peptide-1 for enhanced bone regeneration with in vitro and in vivo evaluations. J Colloid Interface Sci. 2019;539:468–480. doi: 10.1016/j.jcis.2018.12.097. [DOI] [PubMed] [Google Scholar]
- 80.Lin W.C., Yao C., Huang T.Y., Cheng S.J., Tang C.M. Long-term in vitro degradation behavior and biocompatibility of polycaprolactone/cobalt-substituted hydroxyapatite composite for bone tissue engineering. Dent Mater. 2019 Mar 8;(18) doi: 10.1016/j.dental.2019.02.023. pii: S0109-5641. 31460-X. [DOI] [PubMed] [Google Scholar]
- 81.Park J.H., Jung S.Y., Lee C.K. A 3D-printed polycaprolactone/β-tricalcium phosphate mandibular prosthesis: a pilot animal study. The Laryngoscope. 2019 Mar 12 doi: 10.1002/lary.27908. ([Epub ahead of print]) [DOI] [PubMed] [Google Scholar]
- 82.Ho C.C., Fang H.Y., Wang B., Huang T.H., Shie M. The effects of Biodentine/polycaprolactone 3-dimensional-scaffold with odontogenesis properties on human dental pulp cells. Int Endod J. 2018;51(Suppl 4):e291–e300. doi: 10.1111/iej.12799. [DOI] [PubMed] [Google Scholar]
- 83.Fedore C.W., Tse L.Y.L., Nam H.K., Barton K.L. Hatch NE Analysis of polycaprolactone scaffolds fabricated via precision extrusion deposition for control of craniofacial tissue mineralization. Orthod Craniofac Res. 2017;20(Suppl 1):12–17. doi: 10.1111/ocr.12159. [DOI] [PubMed] [Google Scholar]
- 84.Wu Y.A., Chiu Y.C., Lin Y.H., Ho C.C., Shie M.Y., Chen Y.W. 3D-Printed bioactive calcium silicate/poly-ε-caprolactone bioscaffolds modified with biomimetic extracellular matrices for bone regeneration. Int J Mol Sci. 2019;21(4):20. doi: 10.3390/ijms20040942. pii: E942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.da Cunha D.A.L.V., Inforçatti Neto P., Micocci K.C. Fabrication and characterization of scaffolds of poly(ε-caprolactone)/biosilicate® biocomposites prepared by generative manufacturing process. Int J Biom. 2019:2131467. doi: 10.1155/2019/2131467. 2019 Feb 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.González-Gil A.B., Lamo-Espinosa J.M., Muiños-López E. Periosteum-derived mesenchymal progenitor cells in engineered implants promote fracture healing in a critical-size defect rat model. J Tissue Eng Regenerat Med. 2019 Feb 20 doi: 10.1002/term.2821. [DOI] [PubMed] [Google Scholar]
- 87.Nguyen L.T.B., Odeleye A.O.O., Chui C.Y., Baudequin T., Cui Z., Ye H. Development of thermo-responsive polycaprolactone macrocarriers conjugated with Poly(N-isopropyl acrylamide) for cell culture. Sci Rep. 2019 Mar 5;9(1):3477. doi: 10.1038/s41598-019-40242-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Fuchs A., Youssef A., Seher A. A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - an in vitro study. J Cranio-Maxillo-Fac Surg. 2019 Feb 4;(18) doi: 10.1016/j.jcms.2019.01.043. pii: S1010-5182. 30887-4. [DOI] [PubMed] [Google Scholar]
- 89.Wei L.G., Chang H.I., Wang Y. A gelatin/collagen/polycaprolactone scaffold for skin regeneration. Peer J. 2019 Feb 1;7 doi: 10.7717/peerj.6358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Amini A.R., Laurencin C.T., Nukavarapu S.P. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2012;40(5):363–408. doi: 10.1615/critrevbiomedeng.v40.i5.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Karp J.M., Teo G.S.L. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206–216. doi: 10.1016/j.stem.2009.02.001. [DOI] [PubMed] [Google Scholar]
